369 Timing of responses to crizotinib (PF-02341066) in anaplastic lymphoma kinase (ALK)-positive patients with advanced non-small cell lung cancer (NSCLC)
Year: 2010
Type: conference-abstract
Authors: B. Solomon, Y.J. Bang, D.R. Camidge, A.J. Iafrate, E.L. Kwak, R.G. Maki, S.I. Ou, R. Salgia, A. Shaw, J. Clark
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1969435267